Amyris

Amyris, Inc. engages in the provision of bioscience solutions. It offers its products to the health and wellness, clean beauty, and flavor and fragrance markets. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.

Earnings data Q1 2024

The principal business of Tara Gold Resources Corp. is the acquisition, exploration and development of high-quality precious metals projects with potential for economic commercial value. Tara Gold is currently focused on acquiring and developing properties in the natural resource belt of the Sierra Madre Occidental and other prolific areas in the states of Chihuahua, Sonora, and Sinaloa, Mexico.  Tara Gold provides investors growth exposure with a diversified exploration portfolio, multiple multi-million ounce targets and several near term production scenarios. Tara Gold owns equity positions in Cayden Resources Inc. (TSX-V: CYD) and Tara Minerals Corp. (TARM.OB), a public US company which explores and develops high-quality precious & non-precious metals and mineral projects in Mexico.

MGM Resorts

Altria

Penn Entertainment

Scotts Miracle-Gro

Smith & Wesson Brands

UBS Group AG

Sin stocks are considered defensive and tend to remain more stable under tough economic conditions. Here are the top ones to watch in 2021.

7 Sin Stocks to Buy as the World Goes to Hell in a Handbasket

EMERYVILLE, Calif., Oct. 1, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, successfully hosted the fourth webinar in its virtual investor mini-series.

Amyris Hosts Successful Fourth Webinar In Its Virtual Investor Mini-Series

EMERYVILLE, Calif., Sept. 22, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in the Clean Health, Beauty and Wellness markets, today announced that it will host its fourth virtual investor webinar on Tuesday, September 28, 2021.

Amyris To Host Fourth Webinar In Its Virtual Investor Mini-Series

EMERYVILLE, Calif., Sept. 8, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that management  will present at two upcoming investor conferences and provide a business update.

Amyris to Present at Two September Investor Conferences

EMERYVILLE, Calif., Sept. 7, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that, on August 31, it closed the acquisition of Beauty Labs International Ltd.

Amyris Closes Acquisition Of Beauty Labs Combining Synthetic Biology Leadership With Digital Innovation

Carvana

Blink Charging

Livent Corp

Plug Power

As we are in the final trading day of August, the Dow Jones is up 1.3%, the S&P 500 is up 3%, and the Nasdaq is up 4%, month-to-date. Make the most of this market with today's Top Shorts from Q.ai's artificial intelligence.

Carvana Co Ranked Among Today's Top Shorts On The Final Trading Day In August

American Airlines

Arvinas Inc

The Dow Jones gained 65 points, while the S&P 500 and Nasdaq each gained 0.2%. Find opportunities in this market with the best short plays from Q.ai's deep learning algorithms.

American Airlines Group Inc Ranked Among Today's Top Shorts As Investors Await The Fed's Talk On Tapering

The Dow Jones rose about 42 points or 0.1%, the S&P 500 lost 0.08%, and the Nasdaq fell 0.04%. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.

Amyris Inc Among Today's Top Shorts As Investors Await More On Fed's Tapering Plans

EMERYVILLE, Calif., Aug. 26, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of JVN™, a clean hair products brand.

Amyris And Jonathan Van Ness Launch JVN Hair A Transformation In Clean Hair Products

EMERYVILLE, Calif., Aug. 24, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it closed the acquisitions of OLIKA, Inc. (OLIKA), an award-winning clean consumer brand, and MG Empower Ltd.

Amyris Closes Acquisitions Of OLIKA Inc. And MG Empower

Redfin

The Dow Jones is up 150 points, or nearly 0.5%, and the S&P 500 and Nasdaq are each up about 0.5%. Make the most of this market with today's best short plays from Q.ai's deep learning algorithms.

Amyris Among Today's Top Shorts Amid News That The Central Bank Could Taper Its Bond Purchasing Program

EMERYVILLE, Calif., Aug. 23, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of Rose Inc., a clean color cosmetics brand.

Amyris And Rosie Huntington-Whiteley's Rose Inc. Brand Launches Its First Collection Of Beauty Products

Amryris will lead the ESG growth space for years to come. Amyris is providing a sustainable growth solution that will continue to be impactful.

Amyris: Leading The ESG Investing Push

The company announced promising results from a study of its experimental intranasal COVID-19 vaccine.

Why Amyris Stock Jumped Today

EMERYVILLE, Calif., Aug. 20, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced promising in-vivo results in a study of its licensed RNA vaccine through intranasal delivery, developed in collaboration with the Infectious Disease Research Institute (IDRI).

Amyris Achieves Promising In-Vivo Results For Intranasal Delivery Of RNA/NLC Vaccine

The Dow Jones dropped around 145 points or 0.4%, the S&P 500 fell 0.4%, and the Nasdaq dipped 0.5%. Find opportunities in today's market with today's best short plays from Q.ai's artificial intelligence.

Amyris Inc Among Today's Top Shorts As Major Indices Fall Following The Fed's Meeting Minutes

EMERYVILLE, Calif., Aug. 19, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced the launch of Terasana™ Clinical, a clean skincare brand.

Amyris Launches Terasana Clinical Clean Skincare Brand

The 10-year Treasury yield inched up to around 1.27%, the Dow fell 120 points, the S&P 500 dipped about 0.2%, and the Nasdaq stayed nearly flat. If you're looking for a way to play this market, the deep learning algorithms at Q.ai have crunched the data to offer up today's Top Shorts.

AI Identifies Amyris Inc Among Today's Top Shorts As Investors Anticipate The Fed's Next Stimulus Moves

EMERYVILLE, Calif., Aug. 16, 2021 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, announced today that it will be hosting an encore to its first three-part virtual investor mini-series themed "Delivering on the Promise of Synthetic Biology".

Amyris Launches Next Virtual Investor Mini-Series

Tupperware

Markets were slightly lower this morning after the Dow Jones touched all-time highs at the open. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.

Arvinas Inc Ranked Among Today's Top Shorts

Ashland Global Hlds

Danimer Scientific

Dow Inc

Gevo

Huntsman

EcoSynthetix Hits Key Milestones With Its Disruptive Biopolymers

Zymergen

The flashy synthetic-biology start-up ran into a wall that Amyris has already learned how to climb over.

Zymergen's Implosion Makes Amyris a Screaming Buy

To close out August's opening week, the Dow Jones rose 101 points, or 0.3%, the S&P 500 was flat, and the Nasdaq fell 0.4%. Find opportunities in today's market with the best short plays from Q.ai's deep learning algorithms.

Amyris Inc Ranked Among Today's Top Shorts

Amyris, Inc. (AMRS) CEO John Melo on Q2 2021 Results - Earnings Call Transcript

Amyris, Inc. (AMRS) delivered earnings and revenue surprises of -23.08% and -2.63%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

News for Amyris Stock (AMRS)